327 related articles for article (PubMed ID: 24918616)
1. Simultaneous transplantation of hematopoietic stem cells and a vascularized composite allograft leads to tolerance.
Mathes DW; Chang J; Hwang B; Graves SS; Storer BE; Butts-Miwongtum T; Sale GE; Storb R
Transplantation; 2014 Jul; 98(2):131-8. PubMed ID: 24918616
[TBL] [Abstract][Full Text] [Related]
2. Long-term Tolerance Toward Haploidentical Vascularized Composite Allograft Transplantation in a Canine Model Using Bone Marrow or Mobilized Stem Cells.
Chang J; Graves SS; Butts-Miwongtum T; Sale GE; Storb R; Mathes DW
Transplantation; 2016 Dec; 100(12):e120-e127. PubMed ID: 27861292
[TBL] [Abstract][Full Text] [Related]
3. Vascularized composite allograft transplant survival in miniature swine: is MHC tolerance sufficient for acceptance of epidermis?
Cetrulo CL; Torabi R; Scalea JR; Shimizu A; Leto Barone AA; Gillon BC; Tasaki M; Leonard DA; Cormack TA; Villani V; Randolph MA; Sachs DH; Yamada K
Transplantation; 2013 Dec; 96(11):966-74. PubMed ID: 24056624
[TBL] [Abstract][Full Text] [Related]
4. The Effect of MHC Antigen Matching Between Donors and Recipients on Skin Tolerance of Vascularized Composite Allografts.
Shanmugarajah K; Powell H; Leonard DA; Mallard C; Albritton A; Harrington E; Randolph MA; Farkash E; Sachs DH; Kurtz JM; Cetrulo CL
Am J Transplant; 2017 Jul; 17(7):1729-1741. PubMed ID: 28035752
[TBL] [Abstract][Full Text] [Related]
5. A clinically feasible approach to induce delayed tolerance in recipients of prior kidney or vascularized composite allotransplants.
Chen B; Xu H; Corbin DR; Ildstad ST
Transplantation; 2012 Oct; 94(7):671-8. PubMed ID: 22948444
[TBL] [Abstract][Full Text] [Related]
6. Vascularized composite allograft tolerance across MHC barriers in a large animal model.
Leonard DA; Kurtz JM; Mallard C; Albritton A; Duran-Struuck R; Farkash EA; Crepeau R; Matar A; Horner BM; Randolph MA; Sachs DH; Huang CA; Cetrulo CL
Am J Transplant; 2014 Feb; 14(2):343-55. PubMed ID: 24405666
[TBL] [Abstract][Full Text] [Related]
7. Unraveling the Crucial Roles of FoxP3+ Regulatory T Cells in Vascularized Composite Allograft Tolerance Induction and Maintenance.
Anggelia MR; Cheng HY; Chuang WY; Hsieh YH; Wang AYL; Lin CH; Wei FC; Brandacher G; Lin CH
Transplantation; 2021 Jun; 105(6):1238-1249. PubMed ID: 33141809
[TBL] [Abstract][Full Text] [Related]
8. Tolerance to vascularized composite allografts in canine mixed hematopoietic chimeras.
Mathes DW; Hwang B; Graves SS; Edwards J; Chang J; Storer BE; Butts-Miwongtum T; Sale GE; Nash RA; Storb R
Transplantation; 2011 Dec; 92(12):1301-8. PubMed ID: 22082819
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous bone marrow and composite tissue transplantation in rats treated with nonmyeloablative conditioning promotes tolerance.
Xu H; Ramsey DM; Wu S; Bozulic LD; Ildstad ST
Transplantation; 2013 Jan; 95(2):301-8. PubMed ID: 23250336
[TBL] [Abstract][Full Text] [Related]
10. Desensitization and Prevention of Antibody-Mediated Rejection in Vascularized Composite Allotransplantation by Syngeneic Hematopoietic Stem Cell Transplantation.
Wang HD; Fidder SAJ; Miller DT; Furtmüller GJ; Ahmadi AR; Nägele F; Lopez J; Quan A; Budihardjo J; Lough DM; Akpinarli B; Etra JW; Vasilic D; Raimondi G; Lee WPA; Montgomery RA; Sun Z; Brandacher G
Transplantation; 2018 Apr; 102(4):593-600. PubMed ID: 29298238
[TBL] [Abstract][Full Text] [Related]
11. Toward Development of the Delayed Tolerance Induction Protocol for Vascularized Composite Allografts in Nonhuman Primates.
Lellouch AG; Ng ZY; Rosales IA; Schol IM; Leonard DA; Gama AR; Colvin RB; Lantieri LA; Randolph MA; Cetrulo CL
Plast Reconstr Surg; 2020 Apr; 145(4):757e-768e. PubMed ID: 32221215
[TBL] [Abstract][Full Text] [Related]
12. A novel rat full-thickness hemi-abdominal wall/hindlimb osteomyocutaneous combined flap: influence of allograft mass and vascularized bone marrow content on vascularized composite allograft survival.
Ramirez AE; Cheng HY; Lao WW; Wang YL; Wen CJ; Wallace CG; Lin CF; Shih LY; Chuang SH; Wei FC
Transpl Int; 2014 Sep; 27(9):977-86. PubMed ID: 24861714
[TBL] [Abstract][Full Text] [Related]
13. Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.
Duran-Struuck R; Sondermeijer HP; Bühler L; Alonso-Guallart P; Zitsman J; Kato Y; Wu A; McMurchy AN; Woodland D; Griesemer A; Martinez M; Boskovic S; Kawai T; Cosimi AB; Yang YG; Hu Z; Wuu CS; Slate A; Mapara M; Baker S; Tokarz R; D'Agati V; Hammer S; Pereira M; Lipkin WI; Wekerle T; Levings M; Sykes M
Transplantation; 2017 Feb; 101(2):274-283. PubMed ID: 27846155
[TBL] [Abstract][Full Text] [Related]
14. Long-term tolerance to kidney allografts after induced rejection of donor hematopoietic chimerism in a preclinical canine model.
Graves SS; Mathes DW; Georges GE; Kuhr CS; Chang J; Butts TM; Storb R
Transplantation; 2012 Sep; 94(6):562-8. PubMed ID: 22929594
[TBL] [Abstract][Full Text] [Related]
15. Evidence that FoxP3+ regulatory T cells may play a role in promoting long-term acceptance of composite tissue allotransplants.
Bozulic LD; Wen Y; Xu H; Ildstad ST
Transplantation; 2011 Apr; 91(8):908-15. PubMed ID: 21304439
[TBL] [Abstract][Full Text] [Related]
16. A Large-Scale Bank of Organ Donor Bone Marrow and Matched Mesenchymal Stem Cells for Promoting Immunomodulation and Transplant Tolerance.
Johnstone BH; Messner F; Brandacher G; Woods EJ
Front Immunol; 2021; 12():622604. PubMed ID: 33732244
[TBL] [Abstract][Full Text] [Related]
17. Vascularized osteomyocutaneous allografts are permissive to tolerance by induction-based immunomodulatory therapy.
Lin CH; Zhang W; Ng TW; Zhang D; Jiang J; Pulikkottil B; Lakkis F; Gorantla VS; Lee WP; Brandacher G; Zheng XX
Am J Transplant; 2013 Aug; 13(8):2161-8. PubMed ID: 23718897
[TBL] [Abstract][Full Text] [Related]
18. Adipose- and Bone Marrow-Derived Mesenchymal Stem Cells Prolong Graft Survival in Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Zhang W; Schweizer R; Tsuji W; Kostereva N; Fanzio PM; Ravuri S; Solari MG; Cheng HY; Rubin PJ; Marra KG; Gorantla VS
Transplantation; 2015 Sep; 99(9):1765-73. PubMed ID: 26102613
[TBL] [Abstract][Full Text] [Related]
19. The Influence of Timing and Frequency of Adipose-Derived Mesenchymal Stem Cell Therapy on Immunomodulation Outcomes After Vascularized Composite Allotransplantation.
Plock JA; Schnider JT; Schweizer R; Zhang W; Tsuji W; Waldner M; Solari MG; Marra KG; Rubin JP; Gorantla VS
Transplantation; 2017 Jan; 101(1):e1-e11. PubMed ID: 27893612
[TBL] [Abstract][Full Text] [Related]
20. Delivery of Rapamycin Using In Situ Forming Implants Promotes Immunoregulation and Vascularized Composite Allograft Survival.
Sutter D; Dzhonova DV; Prost JC; Bovet C; Banz Y; Rahnfeld L; Leroux JC; Rieben R; Vögelin E; Plock JA; Luciani P; Taddeo A; Schnider JT
Sci Rep; 2019 Jun; 9(1):9269. PubMed ID: 31239498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
